Euclid Advisors’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,416
| Closed | -$297K | – | 17 |
|
|
2016
Q4 | $297K | Sell |
1,416
-3,038
| -68% | -$637K | 6.2% | 2 |
|
|
2016
Q3 | $1.03M | Sell |
4,454
-61,686
| -93% | -$14.2M | 5.92% | 2 |
|
|
2016
Q2 | $15.3M | Buy |
66,140
+124
| +0.2% | +$28.7K | 0.66% | 35 |
|
|
2016
Q1 | $17.7M | Sell |
66,016
-18,286
| -22% | -$4.9M | 0.67% | 35 |
|
|
2015
Q4 | $26.3M | Buy |
84,302
+63,679
| +309% | +$19.9M | 0.8% | 21 |
|
|
2015
Q3 | $5.61M | Sell |
20,623
-29,745
| -59% | -$8.08M | 0.25% | 124 |
|
|
2015
Q2 | $15.3M | Sell |
50,368
-99,592
| -66% | -$30.2M | 0.3% | 106 |
|
|
2015
Q1 | $44.6M | Buy |
+149,960
| New | +$44.6M | 0.82% | 21 |
|
|
2014
Q4 | – | Sell |
-142,110
| Closed | -$34.3M | – | 528 |
|
|
2014
Q3 | $34.3M | Buy |
142,110
+9,570
| +7% | +$2.31M | 0.25% | 92 |
|
|
2014
Q2 | $29.6M | Buy |
132,540
+31,072
| +31% | +$6.93M | 0.21% | 117 |
|
|
2014
Q1 | $20.9M | Buy |
101,468
+28,320
| +39% | +$5.83M | 0.16% | 135 |
|
|
2013
Q4 | $12.3M | Sell |
73,148
-3,740
| -5% | -$628K | 0.1% | 200 |
|
|
2013
Q3 | $11.1M | Buy |
76,888
+31,873
| +71% | +$4.59M | 0.11% | 191 |
|
|
2013
Q2 | $5.68M | Buy |
+45,015
| New | +$5.68M | 0.07% | 274 |
|